MedPath

Prediction of Future Weight Change With Dopamine Transporter

Completed
Conditions
Weight Change, Body
Registration Number
NCT03146429
Lead Sponsor
Pusan National University Hospital
Brief Summary

This is the re-analyzing study of observational study by Parkinson's Progression Markers Initiative

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • males or females with their age of 30 years or older at screening
Exclusion Criteria
  • subjects with a neurological disorder, a first degree relative with idiopathic PD, Montreal Cognitive Assessment score of 26 or less, medications that might interfere with DAT SPECT scans, anticoagulants that might preclude safe completion of the lumbar puncture, or investigational drugs, and a condition that precludes the safe performance of routine lumbar puncture

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Weight change1, 2, 3, 4, 5 year after SPECT

weight change per year until 5 years after SPECT

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath